These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28855524)

  • 21. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
    Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
    Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Kinase STK3 Interacts with the Viral Structural Protein VP1 and Inhibits Foot-and-Mouth Disease Virus Replication.
    Liu H; Xue Q; Zeng Q; Zhu Z; Zheng H
    Biomed Res Int; 2017; 2017():2481348. PubMed ID: 29226127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel chimeric foot-and-mouth disease virus-like particles harboring serotype O VP1 protect guinea pigs against challenge.
    Li H; Li Z; Xie Y; Qin X; Qi X; Sun P; Bai X; Ma Y; Zhang Z
    Vet Microbiol; 2016 Feb; 183():92-6. PubMed ID: 26790940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Foot-and-Mouth Disease Virus Capsid Protein VP1 Interacts with Host Ribosomal Protein SA To Maintain Activation of the MAPK Signal Pathway and Promote Virus Replication.
    Zhu Z; Li W; Zhang X; Wang C; Gao L; Yang F; Cao W; Li K; Tian H; Liu X; Zhang K; Zheng H
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Foot-and-Mouth Disease Virus VP3 Protein Acts as a Critical Proinflammatory Factor by Promoting Toll-Like Receptor 4-Mediated Signaling.
    Zhang J; Li D; Yang W; Wang Y; Li L; Zheng H
    J Virol; 2021 Nov; 95(23):e0112021. PubMed ID: 34524915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
    Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pH Stability of Foot-and-Mouth Disease Virus Particles Is Modulated by Residues Located at the Pentameric Interface and in the N Terminus of VP1.
    Caridi F; Vázquez-Calvo A; Sobrino F; Martín-Acebes MA
    J Virol; 2015 May; 89(10):5633-42. PubMed ID: 25762735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of the VP1/2A junction cleavage by the 3C protease in foot-and-mouth disease virus-infected cells.
    Kristensen T; Normann P; Gullberg M; Fahnøe U; Polacek C; Rasmussen TB; Belsham GJ
    J Gen Virol; 2017 Mar; 98(3):385-395. PubMed ID: 27902359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of a bovine enterovirus-based vector expressing a foot-and-mouth disease virus epitope.
    Chu JQ; Lee YJ; Park JN; Kim SM; Lee KN; Ko YJ; Lee HS; Cho IS; Kim B; Park JH
    J Virol Methods; 2013 Apr; 189(1):101-4. PubMed ID: 23391822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P; Li XM; Jin ML; Peng GQ; Chen HC
    Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a combinatorial RNAi lentivirus vector targeting foot-and-mouth disease virus in vitro and in vivo.
    Zhang X; Zheng H; Xu M; Zhou Y; Li X; Yang F; Liu Q; Shi D
    Mol Med Rep; 2015 Nov; 12(5):6672-8. PubMed ID: 26323462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High expression of foot-and-mouth disease virus structural protein VP1 in tobacco chloroplasts.
    Li Y; Sun M; Liu J; Yang Z; Zhang Z; Shen G
    Plant Cell Rep; 2006 Apr; 25(4):329-33. PubMed ID: 16320056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Foot-and-mouth disease virus (FMDV) with a stable FLAG epitope in the VP1 G-H loop as a new tool for studying FMDV pathogenesis.
    Lawrence P; Pacheco JM; Uddowla S; Hollister J; Kotecha A; Fry E; Rieder E
    Virology; 2013 Feb; 436(1):150-61. PubMed ID: 23228860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective immune responses against foot-and-mouth disease virus by vaccination with a DNA vaccine expressing virus-like particles.
    Jin H; Xiao W; Xiao C; Yu Y; Kang Y; Du X; Wei X; Wang B
    Viral Immunol; 2007 Sep; 20(3):429-40. PubMed ID: 17931113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV).
    Xu H; Bao X; Lu Y; Liu Y; Deng B; Wang Y; Xu Y; Hou J
    Vet Microbiol; 2017 Jun; 205():46-52. PubMed ID: 28622860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequence analysis of the foot and mouth disease virus type O/IRN/2007 VP1 gene from Iranian isolate.
    Soleimanjahi H; Motamedi Sedeh F; Jalilian AR; Mahravani H
    Folia Biol (Praha); 2013; 59(2):93-8. PubMed ID: 23746175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Sleeping Beauty transposon toolbox.
    Ammar I; Izsvák Z; Ivics Z
    Methods Mol Biol; 2012; 859():229-40. PubMed ID: 22367875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus.
    Fang M; Li J; Wang H; Yang M; Zhang Y; Zhou L; Wei H; Yang G; Yu Y; Wei X; Yu Y; Wang L; Wan M
    Biotechnol Lett; 2012 May; 34(5):839-47. PubMed ID: 22286179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion in experimentally infected cattle.
    Fowler V; Bashiruddin JB; Belsham GJ; Stenfeldt C; Bøtner A; Knowles NJ; Bankowski B; Parida S; Barnett P
    Vet Microbiol; 2014 Feb; 169(1-2):58-66. PubMed ID: 24438986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a universal RT-PCR for amplifying and sequencing the leader and capsid-coding region of foot-and-mouth disease virus.
    Xu L; Hurtle W; Rowland JM; Casteran KA; Bucko SM; Grau FR; Valdazo-González B; Knowles NJ; King DP; Beckham TR; McIntosh MT
    J Virol Methods; 2013 Apr; 189(1):70-6. PubMed ID: 23380590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.